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Signi¢cant advances within the ¢eld of laboratory automation
and instrumentation have greatly bene¢ted the pharmaceutical
industry in its quest to discover, develop and monitor the quality
of its products. Necessitated by the need for e¤ciency and greater
productivity, faster and more cost-e¡ective means of analyses exist
in the form of devices made up of complex electromechanical
components, all logically controlled and most with the capability
to interface with sophisticated information systems. This
bene¢t does come with a price, a greater responsibility to
ensure data quality while complying with increased regulatory
requirements. Commitment to this responsibility presents a
substantial challenge to scientists and managers throughout
the industry. Due diligence must be demonstrated. A comprehensive
evaluation of every laboratory system utilized, a solid plan
of action for correcting any known de¢ciencies including
upgrades or complete replacement, and an accurate monitoring
procedure with the ability to measure progress are all absolute
necessities to ensure success. Crossfunctional team e¡ott and
communication must transpire with full managerial support.
Vendors need to be audited, made aware of any functional or
quality inadequacies they possess as well as the pharmaceutical
industry’s expectation for these shortcomings to be rapidly
corrected. Suppliers of these systems should also be encouraged to
provide complete `o¡-the-shelf solutions’ to eliminate the need for
in-house customization. The requirements for regulatory compli-
ance in today’s electronic environment have been well publicized.
The players involved are not only listening, but also taking the
necessary steps to retain and improve e¤ciency without sacri¢cing
quality. With the proper measures, planning and action, a highly
automated, cost-e¡ective and compliant laboratory operation can
become a reality.
Introduction
Global demand for pharmaceutical products is on a
steady increase, thus forcing R&D and quality control
laboratories to employ more eæ cient means of sample
processing. The obvious alternative to achieve this objec-
tive is through automating as much of the sample’ s life
cycle (® gure 1) as possible. Various instrumentation,
equipment and information systems speci® cally designed
for these tasks are commercially available and are
escalating in popularity on an international scale.
The bene® ts associated with using this advanced tech-
nology are not without barriers. Strategic planning is
crucial to orchestrate the considerable amount of consis-
tency required to operate at peak eæ ciency cross divi-
sional and geographical boundaries while maintaining a
steady-state of regulatory compliance.
This technical note was written to advocate a course of
action, which incoprorates the components necessary to
meet the challenges faced by state-of-the-art laboratories.
Although slanted towards the demands of a high
throughput quality control operation, due consideration
will be given to the teamwork, hardware, software and
processes required by all that are involved to achieve
success.
Experimental
A sample’ s life cycle can be divided into ® ve phrases:
receipt, preparation, analysis, data acquisition and pro-
cessing, and data reporting and archival. Standardized
approaches to information sharing infrastructure, ana
lytical methodology (including development and transfer
tactics), instrument platforms, collaborated validation
eå orts and common work practices must be created
and maintained.
Information sharing is the most critical element needed
to obtain this standardized state of operation. Develop-
ment and quality control groups would be the ® rst to
initiate this communication and must include representa-
tion from all analogous sites involved. Once collective
requirements are identi® ed, they can be put under
procedural control and implemented into practice.
The next phase would be to share this information
with external suppliers and solicit responses to determine
whether the organizational expectations can be met.
At this point, a quality selection process can be
accomplished.
A common or compatible information infrastructure
needs to be next on the list of essential components and
will play a major role in all the phases of a samples
lifecycle. This will enable virtually seamless routing of
methods, procedures and data from one site to another as
well as providing the means for a central repository of
communal information that can be controlled and ac-
cessed as needed.
Standardization of the analytical technique and intru-
ment platforms paves the way for smooth and eæ cient
transfers from R&D to quality control laboratories. The
resulting methodology can be shared across multiple sites
with a minimum amount of validation. Retention of the
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189technical expertise gained from the development as well
as the multiuse attributes associated with this practice
stays within the organization. This is of great advantage,
especially when employing automated applications that
can signi® cantly reduce analytical variance and error
when used in a consistent manner.
Once the proper systems are in place, high volume and/
or labour-intense tests should be targeted for automated
sample preparation and analysis. Examples of these types
of tests and laboratory applications are as follows.
Tests:
. Assay and impurities.
. Content uniformity.
. Dissolution.
. Gravimetric determination.
. Particle sizing.
Laboratory applications:
. Robotics (custom and commercial).
. High-performance liquid chromatographs.
. Gas chromatographs.
. Spectrophotometers (UV/VIS and ¯ uorescence).
. Data-acquisition systems.
. Laboratory information management systems.
. Secured network servers and workstations.
After the samples had been prepared and analysed, the
resulting data must be acquired, processed, reported and
archived. Substantial care must be given to the treatment
of all raw and ® nal data due to the regulatory require-
ments involved with these phases of a sample’ s lifecycle.
This is where collaborated validation techniques can
really pay oå in the form of reduced redundancy, and,
most importantly, an increase in compliance consistency
and quality.
Results and discussion
After putting the proper communication channels into
place, such as face-to-face meetings, shared network
directories as well as video- and teleconferencing, the
environment is set to begin strategic planning. The ` one
team’ concept can be implemented, which basically
involves R&D and quality control departments exchan-
ging information during the development phase of an
analytical method and sharing responsibilities during
validation. Emphasis should be placed on automation,
which ultimately will improve eæ ciency. This represents
additional challenges in the areas of consistency and
validation. Laboratory instrumentation and equipment
has to be standardized (identical or proven equivalent).
This task can be accomplished by forming technology
` focus groups’ empowered to make uni® ed decisions
about analytical systems, supplier selection and vali
dation strategies. Implementation of this approach
combines the expertise of the entire corporation and
eventually will yield a compliant and eæ cient laboratory
operation.
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Figure 1. Sample life cycle.
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